(Total Views: 301)
Posted On: 01/13/2018 6:25:33 PM
Post# of 72446
While I think Pfizer is certainly in the running for one or more of our compounds (The Dr. B/Harness connection is strong), I don't think that statement was necessarily pointed at us.
You can check out their R&D presentation where they list Xeljanz and a couple JAK indications under their inflammation section:
https://investors.pfizer.com/investors-overview/default.aspx
A health to IPIX!
You can check out their R&D presentation where they list Xeljanz and a couple JAK indications under their inflammation section:
https://investors.pfizer.com/investors-overview/default.aspx
A health to IPIX!
(0)
(0)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
